LATEST ARTICLES
MOST POPULAR
Bod Unveils Initial Schedule 3 CBD Candidate Trial Results
Australian medical cannabis company Bod Science Limited (ASX:BOD) has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3...
Another Big Month For Connecticut Cannabis Sales
Connecticut racked up more than an estimated $22 million in legal cannabis sales last month according to the state's Department of Consumer Protection.New data...
SA Medical Cannabis Patients Risk Instant Driver’s Licence Loss
New driving laws introduced in South Australia last week have heightened legal risks for SA patients using cannabis medicines containing THC.As of last Monday,...
Medical Cannabis Pilot Study For Seniors Living In Residential Care
A study is to get under way in Ontario, Canada examining the use of cannabis in the long-term care of senior citizens.As in Australia,...

